Benzinga's Top #PreMarket Gainers

By: via Benzinga
MannKind (NASDAQ: MNKD) shares gained 11.50% to $11.15 in pre-market trading following the Friday's conditional FDA approval for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.